Literature DB >> 20025475

Immunolocalisation of fibrin in coronary atherosclerosis: implications for necrotic core development.

Fabio Tavora1, Nathaniel Cresswell, Ling Li, Mary Ripple, Allen Burke.   

Abstract

BACKGROUND: Intraplaque haemorrhage has been shown to be important in necrotic core enlargement. Immunolocalisation of fibrin within progressive stages of plaque progression has not been extensively studied.
METHODS: Histological sections (n = 74) of human coronary arteries were stained immunohistochemically for fibrin II, red blood cell antigen (glycophorin A), and CD31. Plaques were chosen to represent a range of lesions [6 adaptive intimal thickening, AIT (AHA grade I); 4 intimal xanthomas (AHA grade II), 19 pathologic intimal thickening, PIT (AHA grade III, or pre-atheroma); 34 fibroatheromas, FA (AHA grade IV and V); and 11 thin cap fibroatheromas (TCFA, AHA grade IV)].
RESULTS: Fibrin was generally absent in the intima of AIT and PIT, with moderate staining in cores of early FA (2.6 +/- 0.3). All late FA and TCFA demonstrated intracore fibrin, with mean scores of 2.9 +/- 0.3 and 3.0 +/- 0.3, respectively. Intimal vasa vasorum counts increased with intimal fibrin score (p < 0.0001); in 68% of cores with fibrin staining, there was minimal or no evidence of red cell breakdown.
CONCLUSIONS: Fibrin in necrotic cores is present proportional to intraplaque vasa vasorum and before red cells, suggesting leakage of vessels before frank intraplaque haemorrhage. Fibrin may play a role in the bridge between pre-atheroma and atheroma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20025475     DOI: 10.3109/00313020903434348

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  8 in total

1.  Ex vivo differential phase contrast and magnetic resonance imaging for characterization of human carotid atherosclerotic plaques.

Authors:  Romana Meletta; Nicole Borel; Paul Stolzmann; Alberto Astolfo; Jan Klohs; Marco Stampanoni; Markus Rudin; Roger Schibli; Stefanie D Krämer; Adrienne Müller Herde
Journal:  Int J Cardiovasc Imaging       Date:  2015-07-16       Impact factor: 2.357

2.  Molecular MRI of atherosclerotic plaque progression in an ApoE(-/-) mouse model with a CLT1 peptide targeted macrocyclic Gd(III) chelate.

Authors:  Xueming Wu; Niranjan Balu; Wen Li; Yong Chen; Xiaoyue Shi; China M Kummitha; Xin Yu; Chun Yuan; Zheng-Rong Lu
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-09-19

3.  Interaction of cowpea mosaic virus nanoparticles with surface vimentin and inflammatory cells in atherosclerotic lesions.

Authors:  Emily M Plummer; Diane Thomas; Giuseppe Destito; Leah P Shriver; Marianne Manchester
Journal:  Nanomedicine (Lond)       Date:  2012-03-06       Impact factor: 5.307

Review 4.  Molecular magnetic resonance imaging of atherosclerotic vessel wall disease.

Authors:  Dominik Nörenberg; Hans U Ebersberger; Gerd Diederichs; Bernd Hamm; René M Botnar; Marcus R Makowski
Journal:  Eur Radiol       Date:  2015-07-03       Impact factor: 5.315

Review 5.  Molecular imaging to identify the vulnerable plaque--from basic research to clinical practice.

Authors:  Dennis H M Kusters; Jan Tegtmeier; Leon J Schurgers; Chris P M Reutelingsperger
Journal:  Mol Imaging Biol       Date:  2012-10       Impact factor: 3.488

Review 6.  Intraplaque haemorrhages as the trigger of plaque vulnerability.

Authors:  Jean-Baptiste Michel; Renu Virmani; Eloïsa Arbustini; Gerard Pasterkamp
Journal:  Eur Heart J       Date:  2011-03-12       Impact factor: 29.983

7.  Magnetic resonance imaging in heart failure, including coronary imaging: numbers, facts, and challenges.

Authors:  Lisa Adams; Michel Noutsias; Boris Bigalke; Marcus R Makowski
Journal:  ESC Heart Fail       Date:  2017-11-21

Review 8.  Molecular MRI of atherosclerosis.

Authors:  Alkystis Phinikaridou; Marcelo E Andia; Sara Lacerda; Silvia Lorrio; Marcus R Makowski; René M Botnar
Journal:  Molecules       Date:  2013-11-13       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.